Managing Director's scheduled term ends
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shivakumar Pattabhiraman ceased to be Managing Director at the close of 4 November 2026, completing a two-year term that began on 5 November 2024. He also left the Stakeholders Relationship Committee. The filing does not name a successor.
The planned exit limits immediate disruption, although the absence of a named successor could create some leadership uncertainty.